Effects on the Immune System 415Baczynsky WO, Zimmerman AM (1983a) Effects of delta-9-tetrahydrocannabinol, cannabi-
nol and cannabidiol on the immune system in mice. I. In vivo investigation of the
primary and secondary immune response. Pharmacology 26:1–11
Baczynsky WO, Zimmerman AM (1983b) Effects of delta-9-tetrahydrocannabinol, cannabi-
nol and cannabidiol on the immune system in mice. II. In vitro investigation using
cultured mouse splenocytes. Pharmacology 26:12–19
Baldwin GC, Tashkin DP, Buckley DM, Park AN, Dubinett SM, Roth MD (1997) Marijuana
and cocaine impair alveolar macrophage function and cytokine production. Am J Respir
Crit Care Med 156:1606–1613
Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP (1998) Histopathologic and
molecularalterationsinbronchialepitheliuminhabitualsmokersofmarijuana,cocaine,
and/or tobacco. J Natl Cancer Inst 90:1198–1205
Bass R, Engelhard D, Trembovler V, Shohami E (1996) A novel nonpsychotropic cannabi-
noid, HU-211, in the treatment of experimental pneumococcal meningitis. J Infect Dis
173:735–738
Berdyshev E, Boichot E, Corbel M, Germain N, Lagente V (1998) Effects of cannabinoid
receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci 63:L125–
L129
Berdyshev EV, Boichot E, Germain N, Allain N, Anger JP, Lagente V (1997) Influence of fatty
acid ethanolamides and delta-9-tetrahydrocannabinol on cytokine and arachidonate
release by mononuclear cells. Eur J Pharmacol 330:231–240
Blanchard DK, Newton C, Klein TW, Stewart WE, Friedman H (1986) In vitro and in vivo
suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine
spleen cells. Int J Immunopharmacol 8:819–824
Blevins RD, Dumic MP (1980) The effect of delta-9-tetrahydrocannabinol on herpes simplex
virus replication. J Gen Virol 49:427–431
Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G, Casellas P
(1993) Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214:173–
180
Bradley SG, Munson AE, Dewey WL, Harris LS (1977) Enhanced susceptibility of mice to
combinationsof delta-9-tetrahydrocannabinol andlive or killedgram-negative bacteria.
Infect Immun 17:325–329
Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI (2002) Short-
term effects of cannabinoids on immune phenotype and function in HIV-1-infected
patients. J Clin Pharmacol 42:82S–89S
Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled
cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163
Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M, Zimmer A (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid
CB(2) receptor. Eur J Pharmacol 396:141–149
Burnette-Curley D, Cabral GA (1995) Differential inhibition of RAW264.7 macrophage tu-
moricidal activity by delta-9-tetrahydrocannabinol. Proc Soc Exp Biol Med
210:64–76
Burnette-Curley D, Marciano-Cabral F, Fischer-Stenger K, Cabral GA (1993) Delta-9-tetra-
hydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmétte-
Guerin-activated macrophages. Int J Immunopharmacol 15:371–382
Cabral GA, Dove Pettit DA (1998) Drugs and immunity: cannabinoids and their role in
decreased resistance to infectious disease. J Neuroimmunol 83:116–123
Cabral GA, Fischer-Stenger K (1994) Inhibition of macrophage inducible protein expression
by delta-9-tetrahydrocannabinol. Life Sci 54:1831–1844
Cabral GA, Vasquez R (1991) Effects of marijuana on macrophage function. Adv Exp Med
Biol 288:93–105
Cabral GA, Vasquez R (1992) Delta-9-tetrahydrocannabinol suppresses macrophage extrin-
sic antiherpesvirus activity. Proc Soc Exp Biol Med 199:255–263